Shanghai Kaibao Pharmaceutical CO.,Ltd held its 1st Extraordinary General Meeting of 2023 on 22 December 2023, during which the following proposal(s) was/were approved: Election and nomination of non-independent directors, cumulative voting system applicable, Mu Jingwei, non-independent director: Zhou Yingbin, non-independent director, Jing Shuzhong, non-independent director, Liu Jianzhong, non-independent director, Ren Liwang, non-independent director, Zhao Ningbo, non-independent director. Election and nomination of independent directors, cumulative voting system applicable: Ye Zuguang, independent director, Li Zhenni, independent director, Ma Hong, independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.18 CNY | -2.06% | -2.68% | -7.07% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.07% | 913M | |
+31.37% | 588B | |
-3.13% | 364B | |
+19.58% | 326B | |
+5.19% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.70% | 167B | |
+0.49% | 161B |
- Stock Market
- Equities
- 300039 Stock
- News Shanghai Kaibao Pharmaceutical CO.,Ltd
- Shanghai Kaibao Pharmaceutical CO.,Ltd Announces Executive Changes